Literature DB >> 19708126

Chloride channelopathies.

Rosa Planells-Cases1, Thomas J Jentsch.   

Abstract

Channelopathies, defined as diseases that are caused by mutations in genes encoding ion channels, are associated with a wide variety of symptoms. Impaired chloride transport can cause diseases as diverse as cystic fibrosis, myotonia, epilepsy, hyperekplexia, lysosomal storage disease, deafness, renal salt loss, kidney stones and osteopetrosis. These disorders are caused by mutations in genes belonging to non-related gene families, i.e. CLC chloride channels and transporters, ABC transporters, and GABA- and glycine receptors. Diseases due to mutations in TMEM16E and bestrophin 1 might be due to a loss of Ca++-activated Cl- channels, although this remains to be shown.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708126     DOI: 10.1016/j.bbadis.2009.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  35 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXXV: calcium-activated chloride channels.

Authors:  Fen Huang; Xiuming Wong; Lily Y Jan
Journal:  Pharmacol Rev       Date:  2011-11-16       Impact factor: 25.468

Review 2.  Genetic disorders of ion channels.

Authors:  Decha Enkvetchakul
Journal:  Mo Med       Date:  2010 Jul-Aug

3.  An automated pipeline to screen membrane protein 2D crystallization.

Authors:  Changki Kim; Martin Vink; Minghui Hu; James Love; David L Stokes; Iban Ubarretxena-Belandia
Journal:  J Struct Funct Genomics       Date:  2010-03-27

4.  Structural and biophysical properties of a synthetic channel-forming peptide: designing a clinically relevant anion selective pore.

Authors:  U Bukovnik; J Gao; G A Cook; L P Shank; M B Seabra; B D Schultz; T Iwamoto; J Chen; J M Tomich
Journal:  Biochim Biophys Acta       Date:  2011-07-31

5.  No evidence for a role of CLCN2 variants in idiopathic generalized epilepsy.

Authors:  María I Niemeyer; L Pablo Cid; Francisco V Sepúlveda; Judith Blanz; Muriel Auberson; Thomas J Jentsch
Journal:  Nat Genet       Date:  2010-01       Impact factor: 38.330

Review 6.  Salt, chloride, bleach, and innate host defense.

Authors:  Guoshun Wang; William M Nauseef
Journal:  J Leukoc Biol       Date:  2015-06-05       Impact factor: 4.962

7.  Channelopathies and drug discovery in the postgenomic era.

Authors:  Dayue Darrel Duan; Tong-hui Ma
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

8.  Mutation of external glutamate residue reveals a new intermediate transport state and anion binding site in a CLC Cl-/H+ antiporter.

Authors:  Kunwoong Park; Byoung-Cheol Lee; Hyun-Ho Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-13       Impact factor: 11.205

Review 9.  CFTR and TNR-CFTR expression and function in the kidney.

Authors:  Jackson Souza-Menezes; Geórgia da Silva Feltran; Marcelo M Morales
Journal:  Biophys Rev       Date:  2014-05-07

10.  Paul F. Cranefield Award to Merritt C. Maduke.

Authors: 
Journal:  J Gen Physiol       Date:  2010-07       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.